Crosstalk of physiological pH and chemical pKa under the umbrella of physiologically based pharmacokinetic modeling of drug absorption, distribution, metabolism …
L Gaohua, X Miao, L Dou - Expert opinion on drug metabolism & …, 2021 - Taylor & Francis
Introduction: Physiological pH and chemical pKa are two sides of the same coin in defining
the ionization of a drug in the human body. The Henderson-Hasselbalch equation and pH …
the ionization of a drug in the human body. The Henderson-Hasselbalch equation and pH …
Reverse translation in PBPK and QSP: going backwards in order to go forward with confidence
A Rostami‐Hodjegan - Clinical Pharmacology & Therapeutics, 2018 - Wiley Online Library
Significant events have taken place shaping the recent industrialization of physiologically
based pharmacokinetic in vitro–in vivo extrapolation (PBPK‐IVIVE) use in drug …
based pharmacokinetic in vitro–in vivo extrapolation (PBPK‐IVIVE) use in drug …
Systems toxicology: real world applications and opportunities
Systems Toxicology aims to change the basis of how adverse biological effects of
xenobiotics are characterized from empirical end points to describing modes of action as …
xenobiotics are characterized from empirical end points to describing modes of action as …
[HTML][HTML] Metformin and cimetidine: Physiologically based pharmacokinetic modelling to investigate transporter mediated drug–drug interactions
Metformin is used as a probe for OCT2 mediated transport when investigating possible DDIs
with new chemical entities. The aim of the current study was to investigate the ability of …
with new chemical entities. The aim of the current study was to investigate the ability of …
Prediction of maternal and fetoplacental concentrations of cefazolin, cefuroxime, and amoxicillin during pregnancy using bottom-up physiologically based …
K Abduljalil, J Ning, A Pansari, X Pan… - Drug Metabolism and …, 2022 - ASPET
Concerns over maternal and fetal drug exposures highlight the need for a better
understanding of drug distribution into the fetus through the placental barrier. This study …
understanding of drug distribution into the fetus through the placental barrier. This study …
Development of a multicompartment permeability‐limited lung PBPK model and its application in predicting pulmonary pharmacokinetics of antituberculosis drugs
Achieving sufficient concentrations of antituberculosis (TB) drugs in pulmonary tissue at the
optimum time is still a challenge in developing therapeutic regimens for TB. A …
optimum time is still a challenge in developing therapeutic regimens for TB. A …
[HTML][HTML] Application of physiologically based kinetic (PBK) modelling in the next generation risk assessment of dermally applied consumer products
TE Moxon, H Li, MY Lee, P Piechota, B Nicol, J Pickles… - Toxicology in Vitro, 2020 - Elsevier
Abstract Next Generation Risk Assessment (NGRA) is a procedure that integrates new
approach methodologies (NAMs) to assure safety of a product without generating data from …
approach methodologies (NAMs) to assure safety of a product without generating data from …
Towards quantitation of the effects of renal impairment and probenecid inhibition on kidney uptake and efflux transporters, using physiologically based …
Abstract Background and Objectives The kidney is a major drug-eliminating organ. Renal
impairment or concomitant use of transporter inhibitors may decrease active secretion and …
impairment or concomitant use of transporter inhibitors may decrease active secretion and …
Prediction of transporter‐mediated drug‐drug interactions for baricitinib
MM Posada, EA Cannady, CD Payne… - Clinical and …, 2017 - Wiley Online Library
Baricitinib, an oral selective Janus kinase 1 and 2 inhibitor, undergoes active renal tubular
secretion. Baricitinib was not predicted to inhibit hepatic and renal uptake and efflux drug …
secretion. Baricitinib was not predicted to inhibit hepatic and renal uptake and efflux drug …
Quantitative Translation of Microfluidic Transporter in Vitro Data to in Vivo Reveals Impaired Albumin-Facilitated Indoxyl Sulfate Secretion in Chronic Kidney Disease
TK Van Der Made, M Fedecostante… - Molecular …, 2019 - ACS Publications
Indoxyl sulfate (IxS), a highly albumin-bound uremic solute, accumulates in chronic kidney
disease (CKD) due to reduced renal clearance. This study was designed to specifically …
disease (CKD) due to reduced renal clearance. This study was designed to specifically …